AI for Researchers
Proficient · M12 · lesson 12 of 22 · queued
Preview — browse every lesson free. Enroll to mark lessons complete, open partner links and save your progress. Login & enroll →
📖
in this lesson

3.3: Rapid Evidence Assessments

15 min

Overview

Policy makers, clinical guideline developers, and organizational decision-makers routinely need evidence summaries faster than full systematic reviews can provide them. Rapid Evidence Assessments (REAs) occupy a defined methodological space between a narrative literature review and a full systematic review, trading some methodological comprehensiveness for speed while maintaining key elements of systematic review rigor, explicit search strategies, transparent inclusion criteria, and structured synthesis. AI tools have transformed what is achievable in an REA, making it possible for a small team to produce a credible, well-documented evidence summary in weeks rather than months. Understanding both the legitimate shortcuts and the non-negotiable methodological requirements is essential for producing REAs that are useful and defensible.

Title

Lesson 3.3: Rapid Evidence Assessments

Purpose

This lesson teaches researchers how to design and conduct rapid evidence assessments, abbreviated systematic reviews conducted on accelerated timelines to support policy or practice decisions, leveraging AI to maintain rigor under time constraints. You'll learn to identify when rapid assessment is appropriate, where corners can be cut safely, and how AI accelerates processes without compromising critical methodology.


When Rapid Evidence Assessments Are Appropriate

Not every research question justifies the full resources of a systematic review, and not every decision context allows the time one requires. REAs are appropriate when the decision cannot wait for a full review, when a full review already exists and needs updating on a specific sub-question, when the evidence base is known to be limited in scope or volume, or when the question is exploratory, mapping what is known before committing to a full synthesis.

REAs are not appropriate when the decision involves high-stakes clinical or policy choices where comprehensiveness of evidence is critical, when the evidence base is large and heterogeneous (requiring full systematic search and selection procedures), or when the question requires precise effect-size estimation through meta-analysis. Misusing REAs in high-stakes contexts can be worse than no review, because a poorly conducted rapid assessment may give false confidence in an incomplete evidence base.

AI helps at the scoping stage by rapidly summarizing what is already known about the evidence landscape. A prompt like: 'Summarize the volume and types of studies likely available on [topic], major systematic reviews completed in the last five years, and key evidence gaps based on general scientific knowledge' gives you a starting picture of whether REA or full review is more appropriate. This is not a substitute for an actual scoping search but provides a rapid orientation that shapes your methodological decisions.

Clear documentation of the rationale for choosing REA over full systematic review is essential. REA methodology requires explicit acknowledgment of the limitations introduced by abbreviated procedures, and commissioners of the review need to understand what they are getting, and not getting, from a rapid assessment.

Defining Scope and Inclusion Criteria

The most consequential methodological decision in an REA is scope definition. Because you cannot search comprehensively, you must define your PICO (Population, Intervention, Comparator, Outcome) with enough precision to make searching tractable and inclusion decisions efficient. Overly broad scope in an REA produces unmanageable results; overly narrow scope misses relevant evidence.

AI can help you iterate on scope definition quickly. Present your draft PICO and ask the AI to identify potential boundary cases, study designs, populations, or outcomes that are adjacent to your scope but that you haven't yet decided to include or exclude. This rapid mapping of boundary cases helps you make inclusion decisions systematically before searching, rather than ad hoc during screening.

For inclusion criteria, AI can also generate a brief rationale for each criterion, why certain study designs are included, why certain outcome measures qualify, why certain time periods are relevant, that strengthens the documentation of your protocol. REA protocols don't always require PROSPERO registration (depending on context and purpose), but documenting your protocol before searching is still essential for defensibility.

A key decision in REA scope is which study designs to include. Including only RCTs makes the search tractable but may miss relevant observational evidence when RCTs are sparse. Including all study designs makes the search comprehensive but creates a heavy screening burden. AI can help you assess this tradeoff by summarizing the likely study design mix for your topic before you commit to inclusion criteria, allowing a more informed choice.

In a full systematic review, search comprehensiveness is paramount: multiple databases, grey literature, hand-searching reference lists, expert consultation. In an REA, you can legitimately restrict the number of databases searched, limit the grey literature scope, and impose time-period boundaries on the search, provided these restrictions are explicitly documented and their likely impact on completeness is acknowledged.

AI assists with search strategy development in REAs in the same way as full reviews: generating synonyms, structuring Boolean logic, translating strategies across database formats. Where AI specifically adds value in the REA context is speed: what might take a day of search strategy development can be completed in an hour with AI assistance, preserving more of the available time for substantive synthesis.

For title and abstract screening, AI-assisted screening tools have dramatically changed the REA landscape. When screening 500-2000 records, typical for an REA, AI can reduce the human screening burden by 50-70% through first-pass prioritization, allowing the human reviewer to focus attention on the records most likely to be relevant. The critical requirement is calibration: the AI must be given a set of training examples (confirmed includes and excludes) before being trusted with first-pass screening, and a random sample of AI-excluded records should be reviewed to estimate the exclusion error rate.

For full-text screening, AI can pre-process PDFs to extract key eligibility information, sample size, design, population description, outcome measures, and present this in a structured format that allows faster human screening decisions. This is not AI making eligibility decisions; it is AI reducing the time to make each human decision from minutes to seconds.

Streamlined Data Extraction and Synthesis

Full systematic reviews use duplicate extraction (two independent reviewers for each study) with consensus on disagreements. REAs commonly use single extraction with a spot-check by a second reviewer, typically checking 20-30% of extracted studies. AI can assist with the primary extraction, with the human reviewer spot-checking both AI-extracted studies and the selected sample.

The same structured extraction prompt template used in meta-analysis applies here: define all fields, paste the relevant paper sections, collect structured outputs. In an REA, you are likely summarizing study characteristics and findings narratively rather than pooling quantitatively, so extraction fields focus on study design, sample, intervention description, outcomes assessed, and key findings rather than standardized effect sizes.

Synthesis in REAs is most often narrative or tabular: a structured summary of what the included studies found, organized by outcome or by study design, with explicit notation of study quality. AI can assist with the narrative synthesis by drafting summaries of each study's contribution and then aggregating these into themed paragraphs. The researcher reviews each draft to ensure accuracy and adds the interpretive layer that explains what the pattern of findings means for the decision context.

For quality assessment in REAs, abbreviated tools are appropriate: a 5-8 item checklist rather than full risk-of-bias tools is common, applied to all studies. AI can assist with extracting the relevant information for each quality criterion (blinding, allocation, follow-up rate, outcome measurement) from the included studies, with the researcher making the quality judgment for each.

The synthesis output for an REA should be explicitly modest: it should state clearly what the evidence says, note the limitations of the search and selection procedures, quantify the strength and volume of the evidence, and specify what a more comprehensive review would need to do to address the remaining uncertainty. This honest limitation framing is a methodological feature, not a weakness.

The Corners You Cannot Cut

While REAs permit methodological shortcuts in comprehensiveness, certain aspects of systematic review methodology are non-negotiable even under time pressure. These are the elements that make an REA fundamentally different from an informal literature review and that give its findings defensibility.

First, the search strategy must be documented. Even if you search only two databases and impose a five-year time window, the exact search strings, databases, and date restrictions must be recorded and reported. A search that cannot be reproduced cannot be evaluated.

Second, inclusion and exclusion criteria must be defined in advance, not applied flexibly during screening. Making inclusion decisions on a case-by-case basis without pre-specified criteria produces selection bias that can systematically favor studies supporting particular conclusions.

Third, a PRISMA-style flow diagram must be produced, documenting how many records were identified, screened, assessed, and included at each stage. This transparency allows readers to assess the scope of what was searched and what was excluded.

Fourth, quality assessment must be conducted, even if abbreviated. Reporting findings from studies without any quality evaluation misrepresents the strength of the evidence.

Fifth, limitations must be explicitly reported. The REA report must acknowledge that the abbreviated methods may have missed relevant studies, that the search did not include all relevant databases, and that the quality assessment was simplified. This is not a failure of the REA; it is the honest reporting that makes it credible.

AI assists in maintaining these non-negotiable standards under time pressure: generating PRISMA flow text, drafting the search documentation, structuring the limitations section, and formatting quality assessment tables. The speed of AI assistance means that maintaining rigor in these areas no longer requires choosing between thoroughness and timeliness.

Communicating Rapid Assessment Findings in Context

REA findings must be communicated with explicit reference to their methodological limitations and the appropriate scope of conclusions. Policy makers who receive an REA without understanding its limitations may treat it as equivalent to a full systematic review, potentially over-interpreting findings or ignoring important uncertainty.

AI can help draft an executive summary that leads with the key findings, clearly states the methodological approach and its limitations, and specifies what decision contexts the findings do and do not support. A sentence like: 'This rapid evidence assessment searched two major databases for studies published between 2018 and 2026 and should not be treated as a comprehensive summary of the global evidence base' belongs in the executive summary, not buried in the methods.

When presenting REA findings to non-research audiences, AI can help translate technical quality assessment language into plain language that communicates confidence without statistical jargon. 'Most studies had moderate methodological quality, limiting our confidence in the precise size of the effect, though the direction of the evidence was consistent' is more actionable than 'RoB-2 scores ranged from low to high risk.'

Finally, REA findings should be explicitly positioned relative to any existing full systematic reviews on the same topic. If a Cochrane review addressed the same question comprehensively, the REA's value is in updating, extending, or narrowing focus, not replacing, the full review. AI can help you identify and characterize existing full reviews and position the REA's contribution accordingly.